Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accessible, Add, anniversary, Argentine, aspect, auction, binding, biomarker, cat, chairman, chamber, concept, contemplated, correlation, CSL, Cytovax, dander, de, deconsolidate, deconsolidation, deduct, deducted, Deerfield, demand, derecognized, description, dominant, double, doubling, drawn, earmarked, element, encumber, ESRD, extracellular, facto, Fel, forward, guidance, HBsAg, Helix, home, immaterial, indoor, inflamed, issuable, IssueNo, largest, longevity, marked, mask, matrix, mismatched, mortgage, motivated, native, Novated, NP, Oct, ofEITF, overcome, permanent, PHAST, precautionary, preliminarily, proceed, proof, proportionate, recreating, reformulated, rental, repay, Repayment, resolution, revert, SAE, satisfactory, screened, shift, spanning, subordinated, synergistic, Theravax, thousand, tiered, tightly, traditional, uncommon, undelivered, unexercised, VaxInnate, vendor, viability, Wegener, widen
Removed:
Adsorbed, AIC, ALR, anthrax, Ara, authorized, AVA, Basin, biodefense, birch, blocking, cedar, Coley, Cry, daily, deficiency, ease, endemicity, enzyme, estimating, expensive, explore, extensively, France, Green, HIV, importantly, improved, incurring, individualized, ineffective, inhibiting, injectable, inversely, investigated, lab, load, Lol, magnitude, mg, military, molecule, notably, Pacific, Pasteur, pediatric, placement, play, prevalence, preventing, proportional, published, recommended, reconfigured, reflecting, replication, resistant, rest, rPA, secondary, selling, Southeast, statistically, survey, tolerability, toxin, tree, unacceptably, unmodified, worse, younger
Filing tables
Filing exhibits
Related press release
DVAX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on(a) Form S-8 (FileNo. 333-113220) of Dynavax Technologies Corporation pertaining to the 1997 Equity Incentive Plan, the 2004 Stock Incentive Plan and the 2004 Employee Stock Purchase Plan of Dynavax Technologies Corporation,(b) Form S-3 (FileNos. 333-145836 and333-147455) of Dynavax Technologies Corporation and in the related Prospectuses, and(c) Form S-3/A (FileNos. 333-139664,333-134688 and333-147455) of Dynavax Technologies Corporation and in the related Prospectuses of our reports dated March 13, 2008, with respect to the consolidated financial statements of Dynavax Technologies Corporation and the effectiveness of internal control over financial reporting of Dynavax Technologies Corporation, included in this Annual Report(Form 10-K) for the year ended December 31, 2007.
/s/ Ernst & Young LLP
San Francisco, California
March 13, 2008